Can Biomarkers Predict Chemosensitivity in CRS-HIPEC Patients?

Colorectal Cancer - United Kingdom
doi 10.2217/crc-2019-0015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Overall and Disease-Free Survival in Patients Treated With CRS + HIPEC With Cisplatin and Paclitaxel for Gastric Cancer With Peritoneal Carcinomatosis

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2017English

PCI Is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination From High-Grade Appendiceal Primaries

Annals of Surgical Oncology
OncologySurgery
2017English

Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) With Heated Intraperitoneal Chemotherapy (HIPEC)

Annals of Surgical Oncology
OncologySurgery
2016English

Inflammatory Biomarkers Predict Relapse in IBD

Gut
Gastroenterology
2005English

Novel Hematological Biomarkers Predict Survival in Renal Cell Carcinoma Patients Treated With Nephrectomy

Archives of Medical Science
Medicine
2017English

Randomized Controlled Trials Evaluating Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention and Therapy of Peritoneal Metastasis: A Systematic Review

Pleura and Peritoneum
Internal Medicine
2016English

P2.04-10 Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

RIFLE Classification Can Predict Hospital Mortality of Critically Ill Patients

Critical Care
Critical CareIntensive Care Medicine
2009English

Can Exhaled NO Fraction Predict Radiotherapy-Induced Lung Toxicity in Lung Cancer Patients?

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy